Cancer immunology – development of novel anti-cancer therapies

The vast majority of tumours are characterised by high frequencies of genetic and epigenetic alterations resulting in tumour-specific antigens, which may, in principle, be recognised by cytotoxic T cells. Though early clinical immunotherapy trials have yielded mixed results with ambiguous clinical...

Full description

Bibliographic Details
Main Authors: Sacha I Rothschild, Daniela S Thommen, Wolfgang Moersig, Philipp Müller, Alfred Zippelius
Format: Article
Language:English
Published: SMW supporting association (Trägerverein Swiss Medical Weekly SMW) 2015-01-01
Series:Swiss Medical Weekly
Subjects:
Online Access:https://www.smw.ch/index.php/smw/article/view/1988